147 related articles for article (PubMed ID: 32102755)
1. The increase in bone resorption in early-stage type I diabetic mice is induced by RANKL secreted by increased bone marrow adipocytes.
Yang J; Chen S; Zong Z; Yang L; Liu D; Bao Q; Du W
Biochem Biophys Res Commun; 2020 Apr; 525(2):433-439. PubMed ID: 32102755
[TBL] [Abstract][Full Text] [Related]
2. Ovariectomy increases RANKL protein expression in bone marrow adipocytes of C3H/HeJ mice.
Beekman KM; Zwaagstra M; Veldhuis-Vlug AG; van Essen HW; den Heijer M; Maas M; Kerckhofs G; Parac-Vogt TN; Bisschop PH; Bravenboer N
Am J Physiol Endocrinol Metab; 2019 Dec; 317(6):E1050-E1054. PubMed ID: 31526291
[TBL] [Abstract][Full Text] [Related]
3. CCAAT/enhancer binding protein β-deficiency enhances type 1 diabetic bone phenotype by increasing marrow adiposity and bone resorption.
Motyl KJ; Raetz M; Tekalur SA; Schwartz RC; McCabe LR
Am J Physiol Regul Integr Comp Physiol; 2011 May; 300(5):R1250-60. PubMed ID: 21346244
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow adipogenic lineage precursors promote osteoclastogenesis in bone remodeling and pathologic bone loss.
Yu W; Zhong L; Yao L; Wei Y; Gui T; Li Z; Kim H; Holdreith N; Jiang X; Tong W; Dyment N; Liu XS; Yang S; Choi Y; Ahn J; Qin L
J Clin Invest; 2021 Jan; 131(2):. PubMed ID: 33206630
[TBL] [Abstract][Full Text] [Related]
5. Ionizing Radiation Stimulates Expression of Pro-Osteoclastogenic Genes in Marrow and Skeletal Tissue.
Alwood JS; Shahnazari M; Chicana B; Schreurs AS; Kumar A; Bartolini A; Shirazi-Fard Y; Globus RK
J Interferon Cytokine Res; 2015 Jun; 35(6):480-7. PubMed ID: 25734366
[TBL] [Abstract][Full Text] [Related]
6. Licorice isoliquiritigenin suppresses RANKL-induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo.
Zhu L; Wei H; Wu Y; Yang S; Xiao L; Zhang J; Peng B
Int J Biochem Cell Biol; 2012 Jul; 44(7):1139-52. PubMed ID: 22521613
[TBL] [Abstract][Full Text] [Related]
7. Primary human bone marrow adipocytes support TNF-α-induced osteoclast differentiation and function through RANKL expression.
Goto H; Hozumi A; Osaki M; Fukushima T; Sakamoto K; Yonekura A; Tomita M; Furukawa K; Shindo H; Baba H
Cytokine; 2011 Dec; 56(3):662-8. PubMed ID: 21963155
[TBL] [Abstract][Full Text] [Related]
8. Hederagenin protects mice against ovariectomy-induced bone loss by inhibiting RANKL-induced osteoclastogenesis and bone resorption.
Tian K; Su Y; Ding J; Wang D; Zhan Y; Li Y; Liang J; Lin X; Song F; Wang Z; Xu J; Liu Q; Zhao J
Life Sci; 2020 Mar; 244():117336. PubMed ID: 31972206
[TBL] [Abstract][Full Text] [Related]
9. Activation of dimeric glucocorticoid receptors in osteoclast progenitors potentiates RANKL induced mature osteoclast bone resorbing activity.
Conaway HH; Henning P; Lie A; Tuckermann J; Lerner UH
Bone; 2016 Dec; 93():43-54. PubMed ID: 27596806
[TBL] [Abstract][Full Text] [Related]
10. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
11. Obesity-mediated inflammatory microenvironment stimulates osteoclastogenesis and bone loss in mice.
Halade GV; El Jamali A; Williams PJ; Fajardo RJ; Fernandes G
Exp Gerontol; 2011 Jan; 46(1):43-52. PubMed ID: 20923699
[TBL] [Abstract][Full Text] [Related]
12. High-fat diet causes bone loss in young mice by promoting osteoclastogenesis through alteration of the bone marrow environment.
Shu L; Beier E; Sheu T; Zhang H; Zuscik MJ; Puzas EJ; Boyce BF; Mooney RA; Xing L
Calcif Tissue Int; 2015 Apr; 96(4):313-23. PubMed ID: 25673503
[TBL] [Abstract][Full Text] [Related]
13. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
Valverde P; Tu Q; Chen J
J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
[TBL] [Abstract][Full Text] [Related]
14. Toll-Like Receptor 2 Stimulation of Osteoblasts Mediates Staphylococcus Aureus Induced Bone Resorption and Osteoclastogenesis through Enhanced RANKL.
Kassem A; Lindholm C; Lerner UH
PLoS One; 2016; 11(6):e0156708. PubMed ID: 27311019
[TBL] [Abstract][Full Text] [Related]
15. WSS25, a sulfated polysaccharide, inhibits RANKL-induced mouse osteoclast formation by blocking SMAD/ID1 signaling.
Chen C; Qin Y; Fang JP; Ni XY; Yao J; Wang HY; Ding K
Acta Pharmacol Sin; 2015 Sep; 36(9):1053-64. PubMed ID: 26299951
[TBL] [Abstract][Full Text] [Related]
16. Achyranthes bidentata polysaccharide suppresses osteoclastogenesis and bone resorption via inhibiting RANKL signaling.
Song D; Cao Z; Huang S; Tickner J; Li N; Qiu H; Chen X; Wang C; Chen K; Sun Y; Dong S; Xu J
J Cell Biochem; 2018 Jun; 119(6):4826-4835. PubMed ID: 29345352
[TBL] [Abstract][Full Text] [Related]
17. Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis.
Tsentidis C; Gourgiotis D; Kossiva L; Doulgeraki A; Marmarinos A; Galli-Tsinopoulou A; Karavanaki K
Osteoporos Int; 2016 Apr; 27(4):1631-1643. PubMed ID: 26588909
[TBL] [Abstract][Full Text] [Related]
18. Methylsulfonylmethane Inhibits RANKL-Induced Osteoclastogenesis in BMMs by Suppressing NF-κB and STAT3 Activities.
Joung YH; Darvin P; Kang DY; Sp N; Byun HJ; Lee CH; Lee HK; Yang YM
PLoS One; 2016; 11(7):e0159891. PubMed ID: 27447722
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Osteoclastogenesis and Bone Resorption in vitro and in vivo by a prenylflavonoid xanthohumol from hops.
Li J; Zeng L; Xie J; Yue Z; Deng H; Ma X; Zheng C; Wu X; Luo J; Liu M
Sci Rep; 2015 Dec; 5():17605. PubMed ID: 26620037
[TBL] [Abstract][Full Text] [Related]
20. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
Cai X; Xing J; Long CL; Peng Q; Humphrey MB
J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
